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background:  Elevated fibrinogen is associated with short-term major adverse cardiac events (MACE) after percutaneous coronary 
intervention (PCI). The relationship between pre-procedural fibrinogen and long-term MACE after PCI is unknown.
methods:  Individuals undergoing elective or urgent (acute coronary syndrome [ACS]) PCI with thienopyridine pretreatment were enrolled. 
Baseline clinical characteristics, fibrinogen, platelet inhibition (PI)(Accumetrics, San Diego, CA), procedural details, and 2-year MACE 
(myocardial infarction, repeat revascularization, ACS rehospitalization, stroke, death) were recorded.
Results:  332 subjects undergoing PCI (66.0±18.0 years, 70.4% male, 72.1% elective) had a 6-month MACE rate of 37.1%. MACE was 
associated with higher fibrinogen (349.0±123.8 vs 302.8±111.0 mg/dl; p=0.001), total stent length (39.3±25.2 vs 32.2±19.4 mm; p=0.009), 
number of bare-metal stents (0.5±1.0 vs 0.2±0.5; p=0.002), and ACS indication (37.1 vs 18.1%; p<0.001) after univariate and multiple 
variable testing. C-reactive protein (1.1±2.6 vs 0.8±1.5 mg/l; p=0.258) and PI (35.5±27.2 vs 37.3±25.5%; p=0.599) were similar between 
outcome groups. Fibrinogen <280 mg/dl (AUC 0.599; p=0.003) was associated with superior MACE-free survival (75.2 vs 57.0%; p=0.001).
conclusion:  Elevated fibrinogen is associated with 2-year MACE after PCI. Fibrinogen <280 mg/dl is associated with superior MACE-free 
survival.
 
